A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes
- PMID: 9527769
- PMCID: PMC105397
- DOI: 10.1128/AAC.42.2.257
A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes
Abstract
Erythromycin resistance among streptococci is commonly due to target site modification by an rRNA-methylating enzyme, which results in coresistance to macrolide, lincosamide, and streptogramin B antibiotics (MLSB resistance). Genes belonging to the ermAM (ermB) gene class are the only erythromycin resistance methylase (erm) genes in Streptococcus pyogenes with MLSB resistance that have been sequenced so far. We identified a novel erm gene, designated ermTR, from an erythromycin-resistant clinical strain of S. pyogenes (strain A200) with an inducible type of MLSB resistance. The nucleotide sequence of ermTR is 82.5% identical to ermA, previously found, for example, in Staphylococcus aureus and coagulase-negative staphylococci. Our finding provides the first sequence of an erm gene other than ermAM that mediates MLSB resistance in S. pyogenes.
Figures
References
-
- Behnke D, Golubkov V I, Malke H, Boitsov A S, Totolian A A. Restriction endonuclease analysis of group A streptococcal plasmids determining resistance to macrolides, lincosamides and streptogramin-B antibiotics. FEMS Microbiol Lett. 1979;6:5–9.
-
- Brantl S, Kummer C, Behnke D. Complete nucleotide sequence of plasmid pGB3631, a derivative of the Streptococcus agalactiae plasmid pIP501. Gene. 1994;142:155–156. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
